Science Explorer Interactive view Map
Company · Somerville · United States

Finch Therapeutics (United States)

finchtherapeutics.comROR OpenAlex
Research works
17
▲ 504% vs 2013–17
Citations
640
38.4 per fractional work
Top-10% rate
38.1%
record average 16.5%
Open access
66%
world 28%

Not ranked overall: Finch Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.21× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 9.47× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 11.72× its world share, 1 worksImmunology and Micro…Neuroscience: 2.12× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.78× its world share, 0 worksPharmacology, Toxico…Medicine: 1.68× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.7×. Every wedge is a field page.

Which research topics does Finch Therapeutics (United States) publish most on?

By volume in 2022–2025: Clostridium difficile and Clostridium perfringens research, Gut microbiota and health, Drug Transport and Resistance Mechanisms and Virus-based gene therapy research.

Clostridium difficile and Clostridium perfringens research: 1 fractional worksGut microbiota and health: 0 fractional worksDrug Transport and Resis…0Drug Transport and Resistance Mechanisms: 0 fractional worksVirus-based gene therapy…0Virus-based gene therapy research: 0 fractional worksCRISPR and Genetic Engineering: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksAxon Guidance and Neuron…0Axon Guidance and Neuronal Signaling: 0 fractional worksGenomics, phytochemicals, and oxidative stress: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksImmune Cell Function and Interaction: 0 fractional works
Infectious DiseasesMolecular BiologyOncologyGenetics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Clostridium difficile and Clostridium perfringens research Infectious Diseases 1 works
  2. 2 Gut microbiota and health Molecular Biology 0 works
  3. 3 Drug Transport and Resistance Mechanisms Oncology 0 works
  4. 4 Virus-based gene therapy research Genetics 0 works
  5. 5 CRISPR and Genetic Engineering Molecular Biology 0 works
  6. 6 RNA Interference and Gene Delivery Molecular Biology 0 works
  7. 7 Axon Guidance and Neuronal Signaling Cellular and Molecular Neuroscience 0 works
  8. 8 Genomics, phytochemicals, and oxidative stress Molecular Biology 0 works
  9. 9 vaccines and immunoinformatics approaches Molecular Biology 0 works
  10. 10 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.5%not open34.5%

World: 28% of research is openly available.

with international co-authors31.4%domestic only68.6%

World: 19% is written across borders.

How has Finch Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 504% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Somerville

All research institutions in Somerville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.